These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6448578)

  • 1. In vitro evaluation of cefoperazone.
    Hinkle AM; LeBlanc BM; Bodey GP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):423-7. PubMed ID: 6448578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
    Lang SD; Edwards DJ; Durack DT
    Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
    Magnussen CR; Sammartino MT; Ernest KD
    Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative in vitro susceptibility of cefazolin-resistant organisms to six cephalosporins, four penicillins, and three aminoglycosides.
    Chan EL; Birk RJ; Zabransky RJ
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):525-33. PubMed ID: 3851708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
    Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Reimer LG; Mirrett S; Reller LB
    Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mezlocillin: in vitro studies of a new broad-spectrum penicillin.
    Bodey GP; Pan T
    Antimicrob Agents Chemother; 1977 Jan; 11(1):74-9. PubMed ID: 836016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.
    Matsubara N; Minami S; Muraoka T; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1979 Dec; 16(6):731-5. PubMed ID: 316988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro study of temocillin (BRL 17421), a new penicillin.
    Bolivar R; Weaver SS; Bodey GP
    Antimicrob Agents Chemother; 1982 Apr; 21(4):641-5. PubMed ID: 6919412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
    Tarpay MM; Welch DF; Marks MI
    Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
    Welch DF; Matsen JM
    Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
    J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
    Eickhoff TC; Ehret J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of LY127935.
    Fass RJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):503-9. PubMed ID: 518080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial activity of cefpirome, a new cephalosporin with a broad antimicrobial spectrum.
    Arai S; Kobayashi S; Hayashi S; Fujimoto K
    Jpn J Antibiot; 1987 May; 40(5):969-82. PubMed ID: 3669290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jan; 21(1):11-8. PubMed ID: 6805421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.